166 related articles for article (PubMed ID: 26456864)
1. INSM1 increases N-myc stability and oncogenesis via a positive-feedback loop in neuroblastoma.
Chen C; Breslin MB; Lan MS
Oncotarget; 2015 Nov; 6(34):36700-12. PubMed ID: 26456864
[TBL] [Abstract][Full Text] [Related]
2. Sonic hedgehog signaling pathway promotes INSM1 transcription factor in neuroendocrine lung cancer.
Chen C; Breslin MB; Lan MS
Cell Signal; 2018 Jun; 46():83-91. PubMed ID: 29501727
[TBL] [Abstract][Full Text] [Related]
3. 5'-Iodotubercidin represses
Chen C; Breslin MB; Guidry JJ; Lan MS
J Biol Chem; 2019 Apr; 294(14):5456-5465. PubMed ID: 30755485
[TBL] [Abstract][Full Text] [Related]
4. Repurposing a plant alkaloid homoharringtonine targets insulinoma associated-1 in N-Myc-activated neuroblastoma.
Chen C; Wu J; Hicks C; Lan MS
Cell Signal; 2023 Sep; 109():110753. PubMed ID: 37301315
[TBL] [Abstract][Full Text] [Related]
5. MCPIP1 Exogenous Overexpression Inhibits Pathways Regulating MYCN Oncoprotein Stability in Neuroblastoma.
Boratyn E; Nowak I; Durbas M; Horwacik I; Sawicka A; Rokita H
J Cell Biochem; 2017 Jul; 118(7):1741-1755. PubMed ID: 27935099
[TBL] [Abstract][Full Text] [Related]
6. Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer.
Fujino K; Motooka Y; Hassan WA; Ali Abdalla MO; Sato Y; Kudoh S; Hasegawa K; Niimori-Kita K; Kobayashi H; Kubota I; Wakimoto J; Suzuki M; Ito T
Am J Pathol; 2015 Dec; 185(12):3164-77. PubMed ID: 26482608
[TBL] [Abstract][Full Text] [Related]
7. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
8. MYCN induces neuroblastoma in primary neural crest cells.
Olsen RR; Otero JH; García-López J; Wallace K; Finkelstein D; Rehg JE; Yin Z; Wang YD; Freeman KW
Oncogene; 2017 Aug; 36(35):5075-5082. PubMed ID: 28459463
[TBL] [Abstract][Full Text] [Related]
9. Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivo.
Segerström L; Baryawno N; Sveinbjörnsson B; Wickström M; Elfman L; Kogner P; Johnsen JI
Int J Cancer; 2011 Dec; 129(12):2958-65. PubMed ID: 21717457
[TBL] [Abstract][Full Text] [Related]
10. Extra-nuclear activity of INSM1 transcription factor enhances insulin receptor signaling pathway and Nkx6.1 expression through RACK1 interaction.
Zhang T; Chen C; Breslin MB; Song K; Lan MS
Cell Signal; 2014 Apr; 26(4):740-7. PubMed ID: 24407176
[TBL] [Abstract][Full Text] [Related]
11. The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription.
Wong M; Tee AEL; Milazzo G; Bell JL; Poulos RC; Atmadibrata B; Sun Y; Jing D; Ho N; Ling D; Liu PY; Zhang XD; Hüttelmaier S; Wong JWH; Wang J; Polly P; Perini G; Scarlett CJ; Liu T
Cancer Res; 2017 May; 77(9):2522-2533. PubMed ID: 28209620
[TBL] [Abstract][Full Text] [Related]
12. Insulinoma-Associated-1: From Neuroendocrine Tumor Marker to Cancer Therapeutics.
Chen C; Notkins AL; Lan MS
Mol Cancer Res; 2019 Aug; 17(8):1597-1604. PubMed ID: 31113827
[TBL] [Abstract][Full Text] [Related]
13. Interplay: The Essential Role between INSM1 and N-Myc in Aggressive Neuroblastoma.
Chen C; Lan MS
Biology (Basel); 2022 Sep; 11(10):. PubMed ID: 36290282
[TBL] [Abstract][Full Text] [Related]
14. GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.
Fabian J; Lodrini M; Oehme I; Schier MC; Thole TM; Hielscher T; Kopp-Schneider A; Opitz L; Capper D; von Deimling A; Wiegand I; Milde T; Mahlknecht U; Westermann F; Popanda O; Roels F; Hero B; Berthold F; Fischer M; Kulozik AE; Witt O; Deubzer HE
Cancer Res; 2014 May; 74(9):2604-16. PubMed ID: 24419085
[TBL] [Abstract][Full Text] [Related]
15. Rho-associated kinase is a therapeutic target in neuroblastoma.
Dyberg C; Fransson S; Andonova T; Sveinbjörnsson B; Lännerholm-Palm J; Olsen TK; Forsberg D; Herlenius E; Martinsson T; Brodin B; Kogner P; Johnsen JI; Wickström M
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6603-E6612. PubMed ID: 28739902
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal antagonistic regulation of N-myc mRNA by miR‑17 and the neuronal-specific RNA-binding protein HuD.
Samaraweera L; Spengler BA; Ross RA
Oncol Rep; 2017 Jul; 38(1):545-550. PubMed ID: 28560387
[TBL] [Abstract][Full Text] [Related]
17. MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2.
Ding Y; Yang J; Ma Y; Yao T; Chen X; Ge S; Wang L; Fan X
J Exp Clin Cancer Res; 2019 Dec; 38(1):498. PubMed ID: 31856871
[TBL] [Abstract][Full Text] [Related]
18. A promoter-driven assay for INSM1-associated signaling pathway in neuroblastoma.
Chen C; Lan MS
Cell Signal; 2020 Dec; 76():109785. PubMed ID: 32966884
[TBL] [Abstract][Full Text] [Related]
19. BCL11A gene over-expression in high risk neuroblastoma.
Sultan I; Tbakhi A
Cancer Genet; 2020 Jun; 244():30-31. PubMed ID: 32113148
[No Abstract] [Full Text] [Related]
20. Modifications to the INSM1 promoter to preserve specificity and activity for use in adenoviral gene therapy of neuroendocrine carcinomas.
Akerstrom V; Chen C; Lan MS; Breslin MB
Cancer Gene Ther; 2012 Dec; 19(12):828-38. PubMed ID: 23079673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]